The Long Run with Luke Timmerman

← The Long Run with Luke Timmerman9 sept · 1 h 36 min

Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets

Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets9 sept1 h 36 min
Escuchar en SpotifyTambién funciona en tu navegador
5 apps más

Mathai Mammen, CEO of Cambridge, Mass.-based Parabilis Medicine, on developing alpha helical peptide molecules against hard targets of disease.